nach oben

Molecular Autism

Erschienen in:

Open Access 01.12.2015 | Research

Effects of autism spectrum disorders on outcome in teenage-onset anorexia nervosa evaluated by the Morgan-Russell outcome assessment schedule: a controlled community-based study

verfasst von: Søren Nielsen, Henrik Anckarsäter, Carina Gillberg, Christopher Gillberg, Maria Råstam, Elisabet Wentz

Erschienen in: Molecular Autism | Ausgabe 1/2015

Abstract

Background

The purpose of the study was to evaluate time trends and effects of co-existing autism spectrum disorders (ASD) on outcome in an ongoing long-term follow-up study of anorexia nervosa (AN).

Methods

The Morgan-Russell Outcome Assessment Schedule (MROAS) was used at 6-, 10- and 18-year follow-up of a representative sample of 51 individuals with teenage-onset AN and a matched group of 51 healthy comparison cases. The full multinomial distribution of responses for the full scale and each of the subscales was evaluated using exact nonparametric statistical methods. The impact of diagnostic stability of ASD on outcome in AN was evaluated in a dose–response model.

Results

There were no deaths in either group. Food intake and menstrual pattern were initially poor in the AN group but normalised over time. MROAS ‘mental state’ was much poorer in the AN group and did not improve over time. The psychosexual MROAS domains ‘attitudes’ and ‘aims’ showed persistent problems in the AN group. In the MROAS socioeconomic domain, the subscales ‘personal contacts’, ‘social activities’ and ‘employment record’ all showed highly significant between-group differences at all three follow-ups. A statistically significant negative dose–response relationship was found between a stable diagnosis of ASD over time and the results on the subscales ‘mental state’, ‘psychosexual state’ and ‘socio-economic state’.

Conclusions

Outcome of teenage-onset AN is favourable with respect to mortality and persisting eating disorder, but serious problems remain in the domains ‘mental state’, ‘psychosexual function’ and ‘socioeconomic state’. Outcome is considerably worse if ASD is present. Treatment programmes for AN need to be modified so as to accommodate co-existing ASD.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

SN designed the study, conducted the statistical analyses, analysed and interpreted the data, drafted the manuscript and critically revised the manuscript for important intellectual content. HA and CaG participated in acquisition of the data and critically revised the manuscript for important intellectual content. ChG designed the study, analysed and interpreted the data and critically revised the manuscript for important intellectual content. MR and EW designed the study, participated in acquisition of the data, analysed and interpreted the data, drafted the manuscript and critically revised the manuscript for important intellectual content. All authors read and approved the manuscript.

anorexia nervosa

AN study 1

original study at age 16

AN study 2

6-year follow-up at age 21

AN study 3

10-year follow-up at age 24

AN study 4

18-year follow-up at age 32

ASD

autism spectrum disorders

COMP

comparison group

eating disorder

MROAS

Morgan-Russell outcome assessment schedule

MR scores

Morgan-Russell scores

‘never ASD’

individuals who had never been assigned an ASD diagnosis

‘ASD × 1-3’

individuals who had been assigned an ASD diagnosis in at least one study but not at all four studies

‘ASD × 4’

individuals with an ASD diagnosis at all four examinations

Background

Anorexia nervosa (AN) is one of the most serious psychiatric disorders that affect teenagers, predominantly girls, with an increased risk of a chronic course and premature death [1-3]. The prevalence of AN is estimated at 0.3% to 2.2% [3,4]. Long-term outcome in eating disorders (EDs) can be assessed in different areas such as mortality, recovery, psychosocial functioning and psychiatric and somatic comorbidity. Discouraging data on psychosocial outcome of AN was reported by Ratnasuriya and co-workers regarding AN patients at 20-year follow-up [5]. Just over half of the individuals did get married, and even fewer had children. Further, only half the group was employed and one third led a very isolated life. Other follow-up studies confirm that former AN patients marry less often [6,7]. Twelve percent of Swedish women with a history of inpatient treatment for AN had a disability pension at long-term follow-up [8].

The first suggestion of a possible relationship between autism spectrum disorder (ASD) and AN came from Christopher Gillberg more than 30 years ago [9]. Since then, a substantial body of work has been published, theoretical [10-14] as well as clinical and epidemiological [15-17]. Our group has recently contributed to this body of evidence [18,19]. In the Gothenburg study, the AN and the healthy comparison (COMP) groups have so far been examined on four occasions at mean age 16, 21, 24 and 32 [20-24]. At the time of the latest examination, 18 years had elapsed since the onset of AN. Screening for ASD has been part of the four examinations of the AN and COMP groups [18,19]. Thirty-two percent of the AN group have, at one or more occasions, been assigned a diagnosis of ASD, and 12% had ASD in all four waves of the study. The individuals with ASD in the AN group had the worst psychosocial outcome at 18-year follow-up [19,25]. The Gothenburg study has also shown that autistic traits pertaining to social interaction are overrepresented among the first-degree relatives of individuals with AN [26].

Earlier work [25,27] prompted us to perform the present study, with the aim of getting more information out of the Morgan-Russell outcome assessment schedule (MROAS) [28,29] than just the average composite score and general outcome categories, which are conventionally the only reported statistics. In particular, we wanted to analyse the influence of diagnostic stability of ASD on outcome as measured by these scales.

Methods

Participants

Anorexia nervosa group

As a detailed description has been given repeatedly previously [18-25], it should suffice to describe that the AN group consisted of 51 cases of teenage-onset AN. Twenty-three girls and two boys were found via screening of the whole 1970 birth cohort (N: 4,291) (1 girl refused in-depth study leaving 22 girls and 2 boys for examination) in Gothenburg, Sweden. This population-based group was supplemented by another community sample, 26 girls and 1 boy, who were referred to the research team primarily by school health staff. The latter group was born mainly in the period 1971 to 1974. All cases fulfilled DSM-III-R [30] and DSM-IV [31] criteria for AN within a year of the assessment of the original study. These two groups combined constituted the AN group.

Comparison group

For each of the 51 cases with AN, the school nurses selected the same-sexed classmate without a history of an ED closest in age to the index child. These individuals served as healthy controls. Collectively, they were referred to as the COMP group.

Procedure

At all studies, the AN group and the COMP group were examined using identical test batteries. All 102 individuals (51 AN and 51 COMP cases) were examined at baseline, in AN study 1, at age 16, again in AN study 2, at age 21 (the 6-year follow-up), and in AN study 3, at age 24 (the 10-year follow-up). In AN study 4, 45 out of 51 in the AN group were examined in person; five were interviewed over the telephone; and in one case, the mother was interviewed as she did not want to let the research team have access to her daughter. In the COMP group, all 51 were interviewed, 48 in person, and three over the telephone.

At all four examinations, an investigator blinded to the original AN/COMP group status assigned ASD diagnoses. At the time of AN study 1, all mothers took part in an in-depth interview regarding early development and childhood symptoms and behaviours. On the basis of de-identified case notes concerning premorbid history, the blinded investigator assigned diagnoses of ASD [32]. In each follow-up study [19,25], when only three individuals had persisting underweight, a new blinded investigator assigned ASD diagnoses after personal interview (see Table 1). Those individuals who had never been assigned an ASD diagnosis were classified as ‘never ASD’ (n = 34); those who had been assigned an ASD diagnosis in at least one study but not at all four studies were classified as ‘ASD × 1-3’ (n = 10), and those with an ASD diagnosis at all four examinations were classified as ‘ASD × 4’ (n = 6). One woman in the AN group was not assigned an ASD category; she was first diagnosed with ASD after suffering severe traumatic brain injury at about 20 years of age.

Table 1

Instruments used at AN study 1 to AN study 4 to assess ASD

	Type of instrument
AN study 1	Structured interview with mother
AN study 2	Dewey social awareness test [42], checklist for autistic disorder [30] and Asperger’s syndrome [43]
AN study 3	Asperger Syndrome Diagnostic Interview [44], checklist for autistic disorder [31] and Asperger’s syndrome [43]
AN study 4	Asperger Syndrome Diagnostic Interview [44], checklist for autistic disorder [31] and Asperger’s syndrome [43] Autism-Spectrum Quotient [45]

AN study 1 first anorexia nervosa examination, AN study 2 second anorexia nervosa examination, AN study 3 third anorexia nervosa examination, AN study 4 fourth anorexia nervosa examination, ASD autism spectrum disorders.

Instruments

The Morgan-Russell outcome assessment schedule (MROAS) [28] is a widely used and well-validated instrument, originally designed to enhance good clinical practice, monitor change in the individual patient and facilitate comparisons between treatment centres. The revision suggested by Morgan and Hayward [29] was used in this study. Overall outcome was reported after each follow-up of the Gothenburg study [21,22,25] as Morgan-Russell’s average composite score and as general outcome classification (good, intermediate and poor outcome).

In this particular project, we focus on the responses from each individual on each Morgan-Russell scale and subscale [28,29].

Ethics

The study was approved by the human ethics committee at the Medical Faculty of University of Gothenburg. The individuals participated voluntarily after informed consent was obtained.

Data structure

The responses on the Morgan-Russell scales and subscales range from 0 to 12. The individual scales and subscales have three, four or five response categories making the resulting multinomial tables unbalanced with empty cells. In consequence, statistical methods based on normality assumptions cannot be used; and instead, we used exact nonparametric (permutation) statistical methods [33-36]. Computations were performed in the program package StatXact8 [37] on a PC platform.

Statistical analysis

This study is a longitudinal study. The overall design is a repeated measures analysis. The data structure rules out the use of standard methods like one-way repeated measures analysis of variance.

The set of multinomial tables was analysed using exact nonparametric (permutation) methods. Computationally, these analyses are rather demanding; so in most cases, it is not possible to compute an exact P value due to limitations in RAM memory. Consequently, a Monte Carlo option is used. Routinely, the sampling procedure is set to sampling 10,000 tables, which provides an unbiased point estimate and a 99% confidence interval for the true P value.

First, we performed analyses of ‘stratified singly ordered row by column (r × c) contingency tables’. There are three strata, one for each follow-up: AN study 2, 3 and 4. There are two groups: AN and COMP. The analysis is a generalised Cochran-Mantel-Haenszel Test [35]. The H ₀ is no association between the r rows (AN and COMP) and the c columns (response categories) in any of the s strata (AN study 2, 3 and 4).

Second, we analysed for group differences at each point in time. The tables are ‘singly ordered r × c contingency tables’ (the rows (AN or COMP) are unordered, but the columns - the response categories - are ordered), and thus the relevant test is Kruskal-Wallis Test [33]. H ₀ the multinomial probabilities across the response categories are identical in the two groups. Results of the statistical analyses can be found in the right side of the raw data in Tables 2, 3 and 4.

Table 2

Morgan-Russell subscale C (mental state); comparisons between AN and COMP group at 6-, 10- and 18-year follow-up

Follow-up	AN group				COMP group				Singly ordered r × c contingency tables Kruskal-Wallis test	Exact Monte Carlo
	Response category				Response category				Test statistic	P (99% CI)
	0	4	8	12	0	4	8	12
6 year	1	10	13	27	0	0	8	43	13.72	0.0001 (0 to 0.0004)
10 year	1	10	14	26	1	2	4	44	13.91	0 (0 to 0.0005)
18 year	2	10	14	25	1	0	7	43	15.43	0.0001 (0 to 0.0005)
Doubly ordered r × c contingency tables	Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables
Analysis for time trend									Cochran-Mantel-Haenszel test
Test statistic	−0.4583				−0.3885				39.72
Exact Monte Carlo P	0.69				0.77				0
99% CI	0.67 to 0.7				0.76 to 0.78				0 to 0.0005

AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columns.

Table 3

Morgan-Russell subscale E2 (emancipation from family);comparisons between AN and COMP group at 6-, 10- and 18-year follow-up

Follow-up	AN group				COMP group				Singly ordered r × c contingency tables Kruskal-Wallis test	Exact Monte Carlo
	Response category				Response category				Test statistic	P (99% CI)
	0	4	8	12	0	4	8	12
6 year	3	9	9	30	0	2	11	38	4.492	0.032 (0.027 to 0.036)
10 year	2	5	9	35	0	1	12	38	0.948	0.34 (0.33 to 0.35)
18 year	2	3	9	37	0	0	4	47	7.158	0.007 (0.005 to 0.009)
Analysis for time trend doubly ordered r × c contingency tables	Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables Cochran-Mantel-Haenszel test
Test statistic	+1.715				+2.378				15.8
Exact Monte Carlo P	0.097				0.022				0
99% CI	0.09 to 0.104				0.018 to 0.025				0 to 0.0005

AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columns.

Table 4

Morgan Russell subscale E5 (employment record); comparisons between AN and COMP group at 6-, 10- and 18-year follow-up

Follow-up	AN group				COMP group				Singly ordered r × c contingency tables Kruskal-Wallis test	Exact Monte Carlo
	Response category				Response category				Test statistic	P (99% CI)
	0	4	8	12	0	4	8	12
6 year	9	4	5	33	4	3	3	41	3.256	0.077 (0.07 to 0.084)
10 year	8	3	7	33	1	2	3	45	8.245	0.0026 (0.001 to 0.004)
18 year	17	3	7	24	2	2	11	36	9.881	0.001 (0.0002 to 0.002)
Doubly ordered r × c contingency tables Analysis for time trend	Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables Cochran-Mantel-Haenszel test
Test statistic	−1.911				0				22.8
Exact Monte Carlo P	0.06				1				0
99% CI	0.05 to 0.07				0.9995 to 1				0 to 0.0005

AN anorexia nervosa, COMP comparison, CI confidence interval, r × c rows and columns.

Third is the analysis for change over time. Each group is analysed separately. Data is organised as ‘doubly ordered r × c contingency tables’, so the relevant statistical test is linear-by-linear association test [34]. The rows correspond to the different follow-ups, and the columns are the responses. The H ₀ is the identical multinomial probabilities at the three points in time, that is, at AN study 2, 3 and 4. The chosen statistical test is appropriate for detecting departures from the null hypothesis H ₀ of the form H ₁ or H′ ₁ or for detecting the two-sided alternative that either H ₁ or H′ ₁ is true. Hypothesis H ₁ implies that as we move from one row to the next, the probability of the response falling in the next higher category increases. Hypothesis H′ ₁ states the opposite. A large positive value of the test statistic rejects H ₀ in favour of H ₁ (that is, a ‘better’ outcome), while a large negative value rejects H ₀ in favour of H′ ₁ (that is, a ‘worse’ outcome). The results from this statistical test are located below each group at the bottom of the group-difference tables, that is Tables 2, 3 and 4, and at the right side of the dose–response tables, that is Tables 5, 6 and 7.

Table 5

Morgan-Russell subscale C (mental state); dose–response analysis

Dose	AN study 2				AN study 3				AN study 4				Analysis for time trend doubly ordered r × c contingency tables Linear-by-linear association test	Exact Monte Carlo
Dose	Response category				Response category				Response category				Test Statistic	P (99% CI)
	0	4	8	12	0	4	8	12	0	4	8	12
Never ASD	0	4	12	18	0	5	9	20	0	6	8	20	0	1 (0.9995 to 1)
ASD × 1-3	0	3	1	6	0	1	4	5	0	2	3	5	0	1 (0.9995 to 1)
ASD × 4	1	3	0	2	1	3	1	1	2	1	3	0	−0.561	0.69 (0.67 to 0.7)
Dose–response analysis
Doubly ordered r × c contingency tables	Linear-by-linear association test				Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables Cochran-Mantel-Haenszel test
Test statistic	−1.452				−2.56				−2.787				−4.342
Exact Monte Carlo P	0.15				0.008				0.007				0.0001
99% CI	0.14 to 0.16				0.005 to 0.01				0.005 to 0.009				0 to 0.0004

AN anorexia nervosa, AN study 2 second anorexia nervosa examination, AN study 3 third anorexia nervosa examination, AN study 4 fourth anorexia nervosa examination, ASD autism spectrum disorders, never ASD individuals who had never been assigned an ASD diagnosis, ASD × 1–3 those who had been assigned an ASD diagnosis in at least one study, but not at all four studies, ASD × 4 those with an ASD diagnosis at all four examinations, CI confidence interval, r × c rows and columns.

Table 6

Morgan-Russell subscale E2 (emancipation from family); dose–response analysis

Dose	AN study 2				AN study 3				AN study 4				Analysis for time trend doubly ordered r × c contingency tables Linear-by-linear association test	Exact Monte Carlo
	Response category				Response category				Response category				Test statistic	P (99% CI)
	0	4	8	12	0	4	8	12	0	4	8	12
Never ASD	2	5	8	19	2	2	7	23	0	1	5	28	+2.562	0.01 (0.008 to 0.014)
ASD × 1-3	0	2	0	8	0	1	1	8	0	1	2	7	0	1 (0.9995 to 1)
ASD × 4	1	2	0	3	0	2	1	3	2	1	2	1	−0.743	0.54 (0.53 to 0.56)
Dose–response analysis doubly ordered r × c contingency tables	Linear-by-linear association test				Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables Cochran-Mantel-Haenszel test
Test statistic	−0.541				−0.483				−3.814				−2.606
Exact Monte Carlo P	0.6				0.72				0.0005				0.01
99% CI	0.59 to 0.62				0.71 to 0.74				0 to 0.001				0.008 to 0.013

Table 7

Morgan-Russell subscale E5 (employment record); dose–response analysis

Dose	AN study 2				AN study 3				AN study 4				Analysis for time trend doubly ordered r × c contingency tables Linear-by-linear association test	Exact Monte Carlo
	Response category				Response category				Response category				Test statistic	P (99% CI)
	0	4	8	12	0	4	8	12	0	4	8	12
Never ASD	3	3	4	24	4	1	2	27	7	2	6	19	−1.339	0.2 (0.19 to 0.21)
ASD × 1-3	3	1	0	6	0	1	4	5	5	1	0	4	−1.027	0.34 (0.33 to 0.36)
ASD × 4	3	0	0	3	4	1	0	1	4	0	1	1	−0.84	0.48 (0.46 to 0.49)
Dose–response analysis doubly ordered r × c tables	Linear-by-linear association test				Linear-by-linear association test				Linear-by-linear association test				Stratified r × c contingency tables Cochran-Mantel-Haenszel test
Test statistic	−2				−3.22				−2.437				−4.385
Exact Monte Carlo P	0.048				0.002				0.013				0
99% CI	0.043 to 0.054				0.0008 to 0.003				0.01 to 0.016				0 to 0.0005

Fourth, we analysed data of the AN group in a dose–response model in relation to ASD. ‘Dose’ stands for diagnoses, ordered hierarchically into three groups: never ASD, ASD × 1–3, ASD × 4. ‘Response’ is the distribution across the existing response categories. Before any analyses were undertaken, the principal investigators hypothesised that mental, psychosexual and socioeconomic state were likely to be influenced by ASD diagnostic stability; and therefore, data was organised in ‘doubly ordered r × c contingency tables’, and consequently the relevant test was a ‘linear-by-linear association test’ [34]. The COMP group was omitted from these analyses. The results of the statistical tests are located below each study at the bottom of Tables 5, 6 and 7.

All tests were two tailed and conducted at a 5% significance level.

Results

There was no mortality in any group at any follow-up. Any eating disorder, including AN, bulimia nervosa and eating disorder not otherwise specified, occurred in 14, 13 and 6 of the individuals in the AN group at AN study 2, 3 and 4, respectively.

AN group versus COMP group

Generally, the findings from the stratified analysis justified the detailed statistical analyses presented here. The generalised Cochran-Mantel-Haenszel test statistic ranged from 8.7 to 48.2, which translates into exact Monte Carlo P values in the range 0.003 to <0.001. There were three exceptions from this general pattern: ‘attitude towards menses (if not returned)’ - almost all participants had resumed their menstruations, so there was not enough data to compute meaningful and stable figures; the scales ‘attitude to menses (if returned)’ and ‘relationship with nuclear family’ had P values of 0.09.

Food intake

Scale A1 - dietary restriction

The distribution across categories for the variable ‘Dietary restriction’ showed inter-group difference at the first and second follow-up (AN study 2: P < 0.0001; AN study 3: P = 0.0003), and no difference at AN study 4. The change over time was due to improvement in the AN group. The dose–response analysis, that is, presence of ASD, showed that the positive development was limited to the never ASD group (significant positive trend P = 0.0005. Dose–response relationship was not significant at any follow-up).

Scale A2 - worry about body weight or appearance

The distribution across categories for the variable ‘Worry about body weight or appearance’ showed inter-group differences at all follow-ups (AN study 2: P < 0.0001; AN study 3: P < 0.0001; AN study 4: P = 0.018). There was no relationship between the presence of ASD and scale A2 at any follow-up.

Scale A3 - body weight

The difference between the AN and the COMP group was most pronounced at AN study 2 (P < 0.0001), still highly significant at AN study 3 (P = 0.0008) and non-existent at AN study 4 (P = 0.85). This development was the net result of a significant improvement in the AN group and an even more significant negative trend in the COMP group. The dose–response analysis showed that the positive development in body weight was limited to the never ASD group, (P = 0.04). There was no indication of a dose–response effect of ASD on body weight at any follow-up.

Menstrual pattern - scale B

The largest between-group difference was found at AN study 2 (P = 0.004), a smaller difference at AN study 3 (P = 0.03), and no difference at AN study 4. This change over time was mainly due to a significant improvement in the AN group, and it was diminished by a similar, but not significant, tendency in the COMP group. The dose–response analysis showed that the positive trend in the AN group was limited to the never ASD group (P = 0.0003).

Mental state - scale C

There was a highly significant between-group difference at all three follow-ups, with a dominance in the AN group giving responses in the lower categories. There was a lack of change over time (see Table 2). At AN study 3 (P = 0.008) and 4 (P = 0.007), a statistically significant, negative dose–response relationship was documented; that is, the more times ASD was present, the lower the MR scores (see Table 5).

Psychosexual state

Scale D1 - attitude towards sexual matters

The responses for subscale D1 showed significant between-group differences (AN study 2: P = 0.005; AN study 3: P = 0.015; AN study 4: P = 0.02). A statistically significant negative dose–response relationship was evident at AN study 2 (P = 0.02) and 4 (P = 0.0004); that is, the more often ASD was assigned, the more negative attitude towards sexual matters.

Scale D2 - professed aims in sexual relationships

The findings for the subscale D2 showed no significant between-group differences at the three follow-ups. Dose–response analysis did not reach the level of significance at any of the three follow-ups.

Scale D3 - overt sexual behaviour

The distribution across the response categories for subscale D3 indicated significant between-group differences at all three follow-ups (AN study 2: P = 0.0007; AN study 3: P = 0.037; AN study 4: P = 0.05). The group ‘never ASD’ showed a statistically significant positive trend (P = 0.003). A statistically significant negative dose–response relationship was evident at AN study 2 (P = 0.013) and 4 (P = 0.0001).

Scale D4 - attitude to menstruation - if it has returned

The responses in subscale D4 did not indicate significant between-group differences at any point in time, and the development in the two groups over time was almost identical; no significant trend in either group. Dose–response analysis showed no significant difference at any follow-up.

Scale D5 - attitude to menstruation - if it has not returned

Due to few responses (AN study 2: n = 7; AN study 3: n = 7; AN study 4: n = 5), no differences were detected.

Socioeconomic state

Scale E1 - relationship with nuclear family

The responses for subscale E1 indicated strained relationships in the AN group at the first two follow-ups. There was no difference between groups at AN study 4. There was no indication of a significant dose–response relationship at any follow-up.

Scale E2 - emancipation from family

The stratified analysis suggested a large difference between groups in at least one stratum. The Kruskal-Wallis test for between-group differences was significant at AN study 2 (P = 0.032), not significant at AN study 3 (P = 0.34), and highly significant at AN study 4 (P = 0.007) (see Table 3). The detailed analysis indicated a split in the AN-subgroups - there was a significant positive trend in the group never ASD (P = 0.01) but not in the two AN subgroups ASD × 1–3 and ASD × 4, respectively. A highly significant negative dose–response relationship was evident at AN study 4 (P = 0.0005) - the more often ASD was assigned, the less emancipation from family (see Table 3 and 6).

Scale E3 - personal contacts

In subscale E3, there were highly significant between-group differences at all follow-ups (AN study 2: P = 0.0007; AN study 3: P < 0.0001; AN study 4: P = 0.0001). The detailed dose–response analysis showed a significant negative relationship at all three follow-ups (AN study 2: P = 0.0004; AN study 3: P = 0.0045; AN study 4: P = 0.0003).

This dimension of a person’s social life was severely impaired in the AN group at all follow-ups compared with the COMP group (AN study 2: P < 0.0001; AN study 3: P < 0.0001; AN study 4: P = 0.0015). The detailed dose–response analysis showed a significant negative dose–response relationship at all three follow-ups (AN study 2: P = 0.013; AN study 3: P = 0.005; AN study 4: P = 0.005).

Scale E5 - employment record

The employment record, as indicated in subscale E5, seemed to get progressively worse in the AN group. At AN study 2, the between-group difference was approaching the level of statistical significance; and at the next two follow-ups, the differences were clearly significant (see Table 4). The detailed dose–response analysis showed a marginally significant negative dose–response relationship at AN study 2 and a clearly significant negative dose–response relationship at AN study 3 and 4 (see Table 7).

Self-progress rating

Scale G - self-progress rating

Neither time trends nor dose–response relationships were statistically significant.

Discussion

The present study looks at the Morgan-Russell outcome data using a different approach compared to our previous studies [18-22,25]. Here, we analysed the full multinomial distribution across response categories, for all scales and subscales, at each follow-up, using exact nonparametric statistical methods [33-36]. We included analysis of a possible dose–response relationship between the presence of ASD and outcome in the AN group [34].

The major findings were 1) a clear improvement over time of the core anorectic symptoms, that is, food intake, body weight and menstrual pattern according to the MROAS in the AN group; 2) ‘Mental state’ and the psychosexual domains showed lasting problems over time in the AN group; 3) in the socioeconomic domain, the subscales ‘personal contacts’, ‘social activities’ and ‘employment record’ all showed highly significant between-group differences at all three follow-ups; 4) the presence of ASD, especially when present at all examinations, contributed to restricted outcomes in the areas mental, psychosexual and socio-economic state.

There was a distinct improvement over time of the anorectic symptoms, that is, food intake, body weight and menstrual pattern according to the MROAS in the AN group. The improvement was mainly limited to the subgroup never ASD, which constituted the majority of AN cases, corresponding to two thirds of the individuals in the AN group. Mental, psychosexual and socioeconomic state showed no improvement over time. Even though only a small minority still had an ED at follow-up, mental state showed poor results due to other psychiatric disorders in adult years, including affective disorders, ASD and anxiety disorders and obsessive-compulsive disorder in particular [22,25]. Similar psychiatric morbidity has also been reported in other long-term follow-up studies, where alcohol and substance abuse also were prevalent [6,38]. ASD, on the other hand, has only been investigated and diagnosed in follow-up studies by our group.

We have already in previous publications shown that autistic traits and ASD were overrepresented in this sample before AN onset and after recovery. Furthermore, we have shown that in the AN group, obsessive-compulsive personality traits and/or a diagnosis of ASD are predictors for a worse outcome pertaining to global assessment of functioning (GAF) [31] and Morgan-Russell average scale score [25]. This paper presents the dose–response relationship between presence of ASD and outcome according to the Morgan-Russell outcome subscales. The subscales were shown to be related to ASD; the more diagnostic stability of ASD, the worse the outcome. Earlier, ASD research has reported autistic traits dimensionally distributed in the general population [39], and that these traits have dimensional impact on overall functioning. The genetic vulnerability in AN is estimated to be at least 0.50 [40], where one subgroup consisting of 15% to 20% of AN individuals has a predisposition in terms of childhood onset autistic traits. The autistic phenotype makes these individuals more vulnerable for other psychiatric disorders, including EDs. In turn, ED or semi-starvation symptoms can also aggravate the autistic traits and lead to social isolation. The negative organic impact of the brain due to starvation may worsen the load of autism [41]. We suspect that this is the case in some of the individuals in our sample; exhibiting autistic traits in childhood and ending up with a full ASD syndrome after recovery when the core symptoms of the ED have subsided.

The degree of emancipation from family of origin was less than satisfactory in the AN group at AN study 4, 18 years after onset of AN, at age 32. The difficulties pertaining to emancipation from family has previously been elucidated by Ratnasuriya et al. [5] and Löwe et al. [6]. Our results indicate, however, that the problems with emancipation from family only occur among those who have been assigned ASD diagnoses at one or more occasions.

The findings regarding the employment record area require special attention. The largest differences between the AN and the COMP group were seen at AN study 3 and 4, when the individuals were on average 24 and 32 years old, respectively. The phenomenon probably reveals how typically developing individuals, such as in the COMP group, manage to work or study full time in this period of life, while a significant minority of the AN group is not able to adapt to adult life after quitting school. We have previously shown that at mean age 32, one in four has no paid employment due to a psychiatric disability [25]. Even though few individuals have a persisting ED 18 years after AN onset, there are still mental problems, including ASD, that result in poor employment records.

Strengths

Our study population was community based (as opposed to a clinical population) and was matched, and data was collected in a uniform and systematic way both in the AN and the COMP group. The design was longitudinal and prospective with several follow-ups. ASD was ascertained using validated instruments, using researchers blinded to group status. Attrition was zero. The Morgan-Russell outcome assessment schedule is a well-validated and widely used instrument. Age and period effects could be studied effectively. Effects of ASD on outcome were studied in detail in a dose–response model. The statistical models and computations were compatible with the existing data structure.

Limitations

The narrow age range - most cases were born between 1970 and 1974 - limited the possibility to study cohort effects. The study took place in one Swedish city - Gothenburg - which may limit the generalisation of findings. The relatively small cohort gave limited power to study the effect of the different predictors.

Clinical implications

Screening for ASD symptomatology with childhood onset should be part of the initial assessment of AN patients. Treatment programmes should be modified to take account of the special needs of AN patients with ASD. This point is in agreement with conclusions by Huke et al. [17].

Research implications

Our findings need replication, in particular by other research teams with access to population-based controlled samples would be of special interest. In this way, it might be possible to outline the ‘typical’ response of each scale or subscale at different ages in the healthy comparison cases. Possible effects of treatment may also be teased out.

Conclusions

Outcome of teenage-onset AN is favourable with respect to mortality and persisting eating disorder, but serious problems remain in the domains ‘mental state’, ‘psychosexual function’ and ‘socioeconomic state’. Outcome is considerably worse if ASD is present. Screening for ASD should be considered in AN patients with treatment failure.

Acknowledgements

The authors gratefully acknowledge the young people who participated in the original study and all the follow-ups. Birgitta Melander was instrumental in assuring coverage of the original cohort of participants. The main project has been supported by grants from several sources over more than 25 years: Swedish Research Council (grants K2006-21X-20048-01-2, K99-21X-11637-04B, K1999-21X-011251-05B, K97-21X-11637-02B), government grants under the Agreement on Medical Education and Research, The Knut and Alice Wallenberg Foundation, The Söderström Königska Nursing Home Foundation, The Swedish Medical Society, The Göteborg Freemasons, The Vårdal Institute (The Swedish Institute for Health Sciences) and The Wilhelm and Martina Lundgren Foundation.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Steinhausen H-C. Outcome of eating disorders. Child Adolesc Psychiatr Clin N Am. 2009;18(1):225–42.CrossRefPubMed

Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68(7):724.CrossRefPubMed

Keski-Rahkonen A, Hoek HW, Susser ES, Linna MS, Sihvola E, Raevuori A, et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007;164(8):1259–65.CrossRefPubMed

Smink FR, van Hoeken D, Hoek HW. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep. 2012;14(4):406–14.CrossRefPubMedCentralPubMed

Ratnasuriya RH, Eisler I, Szmukler GI, Russell GF. Anorexia nervosa: outcome and prognostic factors after 20 years. Br J Psychiatry. 1991;158:495–502.CrossRefPubMed

Lowe B, Zipfel S, Buchholz C, Dupont Y, Reas DL, Herzog W. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychol Med. 2001;31(5):881–90.PubMed

Linna MS, Raevuori A, Haukka J, Suvisaari JM, Suokas JT, Gissler M. Reproductive health outcomes in eating disorders. Int J Eat Disord. 2013;46(8):826–33.CrossRefPubMed

Hjern A, Lindberg L, Lindblad F. Outcome and prognostic factors for adolescent female in-patients with anorexia nervosa: 9- to 14-year follow-up. Br J Psychiatry. 2006;189:428–32.CrossRefPubMed

Gillberg C. Are autism and anorexia nervosa related? Br J Psychiatry. 1983;142:428.CrossRefPubMed

10.

Happe FG. Annotation: current psychological theories of autism: the “theory of mind” account and rival theories. J Child Psychol Psychiatry. 1994;35(2):215–29.CrossRefPubMed

11.

Happe FG. An advanced test of theory of mind: understanding of story characters’ thoughts and feelings by able autistic, mentally handicapped, and normal children and adults. J Autism Dev Disord. 1994;24(2):129–54.CrossRefPubMed

12.

Tchanturia K, Happé F, Godley J, Bara-Carill N, Treasure J, Schmidt U. Theory of mind in AN. Eur Eat Disord Rev. 2004;12:361–6.CrossRef

13.

Zucker NL, Losh M, Bulik CM, LaBar KS, Piven J, Pelphrey KA. Anorexia nervosa and autism spectrum disorders: guided investigation of social cognitive endophenotypes. Psychol Bull. 2007;133(6):976–1006.CrossRefPubMed

14.

Rastam M. Eating disturbances in autism spectrum disorders with focus on adolescent and adult years. Clinical Neuropsychiatry. 2008;5(1):31–42.

15.

Wentz E, Lacey JH, Waller G, Rastam M, Turk J, Gillberg C. Childhood onset neuropsychiatric disorders in adult eating disorder patients. A pilot study. Eur Child Adolesc Psychiatry. 2005;14(8):431–7.CrossRefPubMed

16.

Oldershaw A, Treasure J, Hambrook D, Tchanturia K, Schmidt U. Is anorexia nervosa a version of autism spectrum disorders? Eur Eat Disord Rev. 2011;19(6):462–74.CrossRefPubMed

17.

Huke V, Turk J, Saeidi S, Kent A, Morgan JF. Autism spectrum disorders in eating disorder populations: a systematic review. Eur Eat Disord Rev. 2013;21(5):345–51.CrossRefPubMed

18.

Gillberg IC, Billstedt E, Wentz E, Anckarsater H, Rastam M, Gillberg C. Attention, executive functions, and mentalizing in anorexia nervosa eighteen years after onset of eating disorder. J Clin Exp Neuropsychol. 2010;32(4):358–65.CrossRefPubMed

19.

Anckarsater H, Hofvander B, Billstedt E, Gillberg IC, Gillberg C, Wentz E,Rastam M. The sociocommunicative deficit subgroup in anorexia nervosa: autism spectrum disorders and neurocognition in a community-based, longitudinal study. Psychol Med. 2011; 1–11.

20.

Rastam M, Gillberg C, Garton M. Anorexia nervosa in a Swedish urban region. A population-based study. Br J Psychiatry. 1989;155:642–6.PubMed

21.

Gillberg IC, Rastam M, Gillberg C. Anorexia nervosa outcome: six-year controlled longitudinal study of 51 cases including a population cohort. J Am Acad Child Adolesc Psychiatry. 1994;33(5):729–39.CrossRefPubMed

22.

Wentz E, Gillberg C, Gillberg IC, Rastam M. Ten-year follow-up of adolescent-onset anorexia nervosa: psychiatric disorders and overall functioning scales. J Child Psychol Psychiatry. 2001;42(5):613–22.CrossRefPubMed

23.

Rastam M, Gillberg C, Wentz E. Outcome of teenage-onset anorexia nervosa in a Swedish community-based sample. Eur Child Adolesc Psychiatry. 2003;12 Suppl 1:I78–90.PubMed

24.

Wentz E, Gillberg IC, Anckarsater H, Gillberg C, Rastam M. Reproduction and offspring status 18 years after teenage-onset anorexia nervosa - a controlled community-based study. Int J Eat Disord. 2009;42(6):483–91.CrossRefPubMed

25.

Wentz E, Gillberg IC, Anckarsater H, Gillberg C, Rastam M. Adolescent-onset anorexia nervosa: 18-year outcome. Br J Psychiatry. 2009;194(2):168–74.CrossRefPubMed

26.

Nilsson EW, Gillberg C, Rastam M. Familial factors in anorexia nervosa: a community-based study. Compr Psychiatry. 1998;39(6):392–9.CrossRefPubMed

27.

Nielsen S, Bára-Carrill N. Family, burden of care and social consequences. In: Treasure J, Schmidt U, van Furth E, editors. Handbook of eating disorders. Chichester: John Wiley & Sons; 2003. p. 191–206.

28.

Morgan HG, Russell GF. Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: four-year follow-up study of 41 patients. Psychol Med. 1975;5(4):355–71.CrossRefPubMed

29.

Morgan HG, Hayward AE. Clinical assessment of anorexia nervosa. The Morgan-Russell outcome assessment schedule. Br J Psychiatry. 1988;152:367–71.CrossRefPubMed

30.

APA. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington DC: American Psychiatric Press; 1987. DSM-III-R.

31.

APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Press; 1994. DSM-IV.

32.

Rastam M. Anorexia nervosa in 51 Swedish adolescents: premorbid problems and comorbidity. J Am Acad Child Adolesc Psychiatry. 1992;31(5):819–29.CrossRefPubMed

33.

Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. 2nd ed. New York: McGraw-Hill; 1988.

34.

Agresti A. Categorical data analysis. 2nd ed. New York: John Wiley & Sons; 2002.CrossRef

35.

Mantel N, Byar DP. Marginal homogeneity, symmetry and independence. Communication in Statistics. 1978;A7:953–76.CrossRef

36.

Landis R, Heyman ER, Koch GG. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Communication in Statistics. 1978;46:237–54.

37.

Inc. C. StatXact8 user manual. Cambridge MA: Cytel Inc; 2007.

38.

Sullivan PF, Bulik CM, Fear JL, Pickering A. Outcome of anorexia nervosa: a case–control study. Am J Psychiatry. 1998;155(7):939–46.CrossRefPubMed

39.

Lundstrom S, Chang Z, Rastam M, Gillberg C, Larsson H, Anckarsater H, et al. Autism spectrum disorders and autistic like traits: similar etiology in the extreme end and the normal variation. Arch Gen Psychiatry. 2012;69(1):46–52.CrossRefPubMed

40.

Bulik CM, Thornton LM, Root TL, Pisetsky EM, Lichtenstein P, Pedersen NL. Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample. Biol Psychiatry. 2010;67(1):71–7.CrossRefPubMedCentralPubMed

41.

Schulte-Ruther M, Mainz V, Fink GR, Herpertz-Dahlmann B, Konrad K. Theory of mind and the brain in anorexia nervosa: relation to treatment outcome. J Am Acad Child Adolesc Psychiatry. 2012;51(8):832–41. e11.CrossRefPubMed

42.

Dewey M. Living with Asperger’s syndrome. In: Frith U, editor. Autism and Asperger syndrome. Cambridge, England: Cambridge University Press; 1991. p. 184–206.CrossRef

43.

Gillberg IC, Gillberg C. Asperger syndrome - some epidemiological considerations: a research note. J Child Psychol Psychiatry. 1989;30(4):631–8.CrossRefPubMed

44.

Gillberg C, Rastam M, Wentz E. The Asperger Syndrome (and high-functioning autism) Diagnostic Interview (ASDI): a preliminary study of a new structured clinical interview. Autism. 2001;5(1):57–66.CrossRefPubMed

45.

Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1):5–17.CrossRefPubMed

Titel: Effects of autism spectrum disorders on outcome in teenage-onset anorexia nervosa evaluated by the Morgan-Russell outcome assessment schedule: a controlled community-based study
verfasst von: Søren Nielsen
Henrik Anckarsäter
Carina Gillberg
Christopher Gillberg
Maria Råstam
Elisabet Wentz
Publikationsdatum: 01.12.2015
Verlag: BioMed Central
Erschienen in: Molecular Autism / Ausgabe 1/2015
Elektronische ISSN: 2040-2392
DOI: https://doi.org/10.1186/s13229-015-0013-4

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Competing interests

Authors’ contributions

Background

Methods

Participants

Anorexia nervosa group

Comparison group

Procedure

Instruments

Ethics

Data structure

Statistical analysis

Results

AN group versus COMP group

Food intake

Scale A1 - dietary restriction

Scale A2 - worry about body weight or appearance

Scale A3 - body weight

Menstrual pattern - scale B

Mental state - scale C

Psychosexual state

Scale D1 - attitude towards sexual matters

Scale D2 - professed aims in sexual relationships

Scale D3 - overt sexual behaviour

Scale D4 - attitude to menstruation - if it has returned

Scale D5 - attitude to menstruation - if it has not returned

Socioeconomic state

Scale E1 - relationship with nuclear family

Scale E2 - emancipation from family

Scale E3 - personal contacts

Scale E4 - social activities

Scale E5 - employment record

Self-progress rating

Scale G - self-progress rating

Discussion

Strengths

Limitations

Clinical implications

Research implications

Conclusions

Acknowledgements

Competing interests

Authors’ contributions

Weitere Artikel der Ausgabe 1/2015

Role of the cytoplasmic isoform of RBFOX1/A2BP1 in establishing the architecture of the developing cerebral cortex

Visuo-tactile integration in autism: atypical temporal binding may underlie greater reliance on proprioceptive information

Atypical sympathetic arousal in children with autism spectrum disorder and its association with anxiety symptomatology

A longitudinal twin study of the association between childhood autistic traits and psychotic experiences in adolescence

Early sex differences are not autism-specific: A Baby Siblings Research Consortium (BSRC) study

Insistence on sameness relates to increased covariance of gray matter structure in autism spectrum disorder

Neu in den Fachgebieten Neurologie und Psychiatrie

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

Schutz der Synapsen bei Alzheimer

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid